To evaluate the potential impact of TLQP-21 administration on amyloid phenotype in a mouse model, osmotic pumps were implanted in 3 month old male and female 5xFAD, a transgenic mouse amyloidosis model that expresses five familial AD mutation in APP and presenilin [34]. This evidence concerns the gene APP and amyloidosis.